AGTR1 and Parkinson disease: In conclusion, the results further support the major role of AT1 receptors in dopaminergic degeneration and PD, where the most vulnerable neurons have the highest expression of the AT1 receptor gene (3), and support several recent clinical studies (30) observing the neuroprotective effects of AT1 receptor blockers (i.e. sartans) on PD risk and progression.